We compared different prime-boost regimens and analyzed the induced cancer-specific CD8 T-cell response against the well-established Adpgkmut MHC class I epitope, the naturally occurring dominant neoantigen derived from the murine colon cancer cell line MC-38 [15]. The gene discussed is CD8A; the disease is colonic neoplasm.